Daniel Janney, Director at Krystal Biotech, Inc. (KRYS), sold 100,000 shares at $70.50 ($7.0M) on 2021-12-10, disclosed to the SEC on 2021-12-14.
Open-market sale of $7.0M KRYS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KRYS | SELL | 2023-06-09 | $8.3M | — | Filing → |
| KRYS | SELL | 2023-05-23 | $4.8M | — | Filing → |
| KRYS | SELL | 2023-05-11 | $1.6M | — | Filing → |